Literature DB >> 6345720

Canine distemper infection in mice: characterization of a neuro-adapted virus strain and its long-term evolution in the mouse.

A Bernard, T F Wild, M F Tripier.   

Abstract

The Onderstepoort strain of canine distemper virus (CDV) which has been adapted to newborn Swiss mice was used in a study in weanling mice. Intracerebral inoculation of newborn mice with either the parent or mouse-adapted virus strain led to mortality in 100% of the animals. In weanling mice the parent virus produced less than 10% mortality, whereas the mouse-adapted strain killed approximately 40% of the animals and this was not dose-dependent. Although a meningitis was observed in the surviving mice, the occurrence of viral antigens was less widespread in the brain of weanling mice than in the brain of newborn mice, and could not be detected more than 5 months after infection. In long-term experiments two phenomena were observed. At 4 to 6 months post-infection up to 30% of the mice became obese; however, no viral antigens were detected in the brains. At 13 to 17 months post-infection a number of mice became paralysed and virus antigen could be detected in the brain and lymph glands; however, infectious virus could not be isolated. These observations are discussed in relation to neurological infection and metabolic disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345720     DOI: 10.1099/0022-1317-64-7-1571

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Animal models of postinfectious obesity: hypothesis and review.

Authors:  M J Lyons; K Nagashima; J B Zabriskie
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  Rinderpest and peste des petits ruminants viruses exhibit neurovirulence in mice.

Authors:  Sareen E Galbraith; Stephen McQuaid; Louise Hamill; L Pullen; Thomas Barrett; S Louise Cosby
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

3.  Infectious Progression of Canine Distemper Virus from Circulating Cerebrospinal Fluid into the Central Nervous System.

Authors:  Akiko Takenaka; Hiroki Sato; Fusako Ikeda; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

4.  Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus.

Authors:  A Bernard; R Cohen; S T Khuth; B Vedrine; O Verlaeten; H Akaoka; P Giraudon; M F Belin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression.

Authors:  S T Khuth; H Akaoka; A Pagenstecher; O Verlaeten; M F Belin; P Giraudon; A Bernard
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Imprints of virus infection: can paramyxoviruses permanently modify triacylglycerol metabolism?

Authors:  T F Wild; A Bernard; N A Malak; G Brichon; G Zwinglestein
Journal:  Lipids       Date:  1986-09       Impact factor: 1.880

7.  Canine distemper virus DNA vaccination induces humoral and cellular immunity and protects against a lethal intracerebral challenge.

Authors:  N Sixt; A Cardoso; A Vallier; J Fayolle; R Buckland; T F Wild
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Persistent virus infection associated with chemical manifestations of diabetes. II. Role of viral strain, environmental insult, and host genetics.

Authors:  A Tishon; M B Oldstone
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

9.  Astrocytic reaction predominance in chronic encephalitis of Junin virus-infected rats.

Authors:  E F Lascano; M I Berría; M M Avila; M C Weissenbacher
Journal:  J Med Virol       Date:  1989-12       Impact factor: 2.327

Review 10.  Chronic viral infections of the central nervous system: Aspects specific to multiple sclerosis.

Authors:  P Giraudon; A Bernard
Journal:  Rev Neurol (Paris)       Date:  2009-08-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.